Ironwood Pharmaceuticals Overview

  • Founded
  • 1998
Founded
  • Status
  • Public
  • Employees
  • 232
Employees
  • Stock Symbol
  • IRWD
Stock Symbol
  • Share Price
  • $10.11
  • (As of Friday Closing)

Ironwood Pharmaceuticals General Information

Description

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Contact Information

Website
www.ironwoodpharma.com
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Primary Office
  • 100 Summer Street
  • Suite 2300
  • Cambridge, MA 02110
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ironwood Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.11 $9.99 $7.99 - $12.55 $1.63B 161M 1.84M $0.67

Ironwood Pharmaceuticals Financials Summary

In Thousands,
USD 		TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,964,369 1,964,369 2,383,287 1,843,962
Revenue 389,523 389,523 428,413 346,639
EBITDA 139,135 139,135 98,283 (147,402)
Net Income 106,176 106,176 21,505 (282,368)
Total Assets 559,238 559,238 402,748 332,050
Total Debt 453,702 453,702 431,222 413,923
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ironwood Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ironwood Pharmaceuticals‘s full profile, request access.

Request a free trial

Ironwood Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segmen
Pharmaceuticals
Cambridge, MA
232 As of 2020
00000
000000000 00000

0000000

, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000 000000000
Fremont, CA
00 As of 0000
00000
000000000 00000

00000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
0000000000000
San Francisco, CA
0 As of 0000
0000
000000000 - 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ironwood Pharmaceuticals Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ardelyx Formerly VC-backed Fremont, CA 00 00000 000000000 00000
00000000 Venture Capital-Backed San Francisco, CA 0 0000 000000000 - 0000
0000000 Private Equity-Backed San Diego, CA 000 00000 000000000 - 00000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000&0
000000 000000000 Formerly Angel backed Delray Beach, FL 00 000.00 000000000 000.00
You’re viewing 5 of 23 competitors. Get the full list »

Ironwood Pharmaceuticals Executive Team (25)

Name Title Board Seat Contact Info
Mark Mallon Chief Executive Officer & Board Member
Mark Currie Ph.D Board Member & President
Thomas McCourt President and Interim Chief Executive Officer
Gina Consylman Chief Financial Officer & Senior Vice President
Jason Rickard Chief Operating Officer, Operations & Senior Vice President
You’re viewing 5 of 25 executive team members. Get the full list »

Ironwood Pharmaceuticals Board Members (18)

Name Representing Role Since
000000000 000000 00.0 Self Board Member 000 0000
00000000 0000000 00.0 Self Board Member, Advisory Team 000 0000
000000 00000 Self Board Member 000 0000
000 0000000 Self Board Member 000 0000
00000 000000 Self Chairman & Board Member 000 0000
You’re viewing 5 of 18 board members. Get the full list »

Ironwood Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ironwood Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ironwood Pharmaceuticals‘s full profile, request access.

Request a free trial

Ready to get started?

Request a free trial